CRISTOFERI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.125
EU - Europa 2.301
AS - Asia 802
SA - Sud America 13
AF - Africa 4
Totale 6.245
Nazione #
US - Stati Uniti d'America 3.105
IT - Italia 777
DE - Germania 370
SG - Singapore 345
SE - Svezia 343
IE - Irlanda 262
RU - Federazione Russa 216
CN - Cina 171
GB - Regno Unito 147
HK - Hong Kong 115
ID - Indonesia 39
IN - India 38
VN - Vietnam 32
FI - Finlandia 31
FR - Francia 27
NL - Olanda 21
DK - Danimarca 20
CA - Canada 19
MY - Malesia 18
UA - Ucraina 17
BE - Belgio 15
TR - Turchia 13
AT - Austria 8
PT - Portogallo 8
BR - Brasile 7
ES - Italia 7
IL - Israele 7
CZ - Repubblica Ceca 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
GR - Grecia 4
LT - Lituania 4
MM - Myanmar 4
AR - Argentina 3
IQ - Iraq 3
KR - Corea 3
CH - Svizzera 2
EC - Ecuador 2
GH - Ghana 2
IR - Iran 2
JP - Giappone 2
PK - Pakistan 2
RO - Romania 2
BG - Bulgaria 1
CO - Colombia 1
EE - Estonia 1
LK - Sri Lanka 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 6.245
Città #
Ann Arbor 862
Frankfurt am Main 337
Singapore 307
Milan 276
Dublin 248
Fairfield 231
Chandler 220
Wilmington 178
New York 124
Ashburn 118
Hong Kong 108
Chicago 105
Woodbridge 104
Santa Clara 102
London 90
Seattle 85
Houston 84
Cambridge 81
Princeton 72
Shanghai 64
Rome 48
Dearborn 44
Jakarta 39
Lawrence 35
Altamura 28
Florence 25
Helsinki 25
Beijing 24
Boardman 21
San Diego 21
Monza 17
Pune 17
Penang 16
Los Angeles 15
Nanjing 15
Brussels 14
Jacksonville 13
Turin 13
Andover 12
Bologna 11
Modena 9
Paris 9
Seregno 9
Toronto 9
Bari 8
Lisbon 8
Mumbai 8
Fremont 7
Guangzhou 7
Naples 7
Treviglio 7
Bratislava 6
Brno 6
Central 6
Desio 6
Detroit 6
Genoa 6
Kocaeli 6
Lissone 6
Padova 6
Cagliari 5
Delmar 5
Lappeenranta 5
São Paulo 5
Vienna 5
Appiano Gentile 4
Castiglione del Lago 4
Changsha 4
Council Bluffs 4
Dong Ket 4
Hangzhou 4
Jiaxing 4
Jinan 4
Kilburn 4
Meda 4
Norwalk 4
Shenyang 4
Udine 4
Athens 3
Carate Brianza 3
Chioggia 3
Comazzo 3
Cossato 3
Dongguan 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Giv‘at Shmuel 3
Hebei 3
Hounslow 3
Huizen 3
Istanbul 3
Kunming 3
Lodi 3
Lucca 3
Moscow 3
New Taipei 3
Oslo 3
Taipei 3
Terni 3
Totale 4.534
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 424
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 237
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 224
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 193
Precision medicine in primary biliary cholangitis 186
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 183
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 177
Risk stratification in primary sclerosing cholangitis 176
Endocrinology and Metabolic Diseases (Including Diabetes) 170
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 167
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 166
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 166
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 165
New Therapeutic Targets in Autoimmune Cholangiopathies 159
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 154
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 152
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 151
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 145
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 139
Prognostic models in primary biliary cholangitis 137
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 130
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 128
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 127
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 124
The immunobiology of female predominance in primary biliary cholangitis 120
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 119
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 110
Fibrocystic liver disease 108
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 106
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 101
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 90
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 84
A Smooth Esophageal Stricture Causing Dysphagia 81
Individualizing Care: Management Beyond Medical Therapy 79
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 76
Antioxidant treatment for acute pancreatitis 72
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 69
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 67
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 64
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 64
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 60
Artificial intelligence for precision medicine in autoimmune liver disease 58
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 58
Transient elastography in chronic liver disease: beware to the cut-offs! 58
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 56
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 53
An update on novel pharmacological agents for primary sclerosing cholangitis 52
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 49
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 48
X marks the spot in autoimmunity 48
The Role of Epigenetics in Primary Biliary Cholangitis 43
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 41
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 39
Systematic review-Pancreatic involvement in inflammatory bowel disease 37
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 36
Primary Sclerosing Cholangitis 35
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 34
Elastography in Autoimmune Liver Diseases 32
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 26
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 24
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 22
Individualizing Care: Management Beyond Medical Therapy 21
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 21
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 19
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 15
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 13
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 11
Totale 6.599
Categoria #
all - tutte 29.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020390 0 0 0 0 0 65 80 59 59 69 42 16
2020/20211.133 29 25 184 66 88 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20251.137 195 303 153 143 233 110 0 0 0 0 0 0
Totale 6.599